Drug Discovery and Development Researchers are vital professionals responsible for the early-stage identification and creation of new therapeutic drugs. Their work begins with understanding the biological basis of diseases, identifying potential drug targets, and screening chemical compounds or biologics that could modify disease processes. These researchers employ a wide range of techniques, including high-throughput screening, molecular modeling, and bioinformatics, to discover promising drug candidates. Their role is crucial in ensuring that novel compounds are not only effective but also safe for use in humans. The discovery process often involves collaboration across multiple disciplines, including chemistry, biology, and pharmacology.
Once promising drug candidates are identified, drug discovery and development researchers guide these compounds through the rigorous stages of preclinical and clinical testing. This includes optimizing drug formulations, determining appropriate dosages, and assessing pharmacokinetics and toxicity profiles. These researchers are responsible for advancing potential drugs from the laboratory to the clinic, ensuring compliance with regulatory standards and minimizing risks for patients. As the field of drug development evolves, these researchers are embracing new technologies such as artificial intelligence and precision medicine to streamline the process and create more targeted, effective therapies. Their work continues to push the boundaries of medical science, offering the potential to cure diseases and improve health outcomes on a global scale.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia